Clinical Study

A Phase I Dose-Finding Study Of Metformin In Combination With Concurrent Cisplatin And Radiation In Patients With Locally Advanced Head And Neck Squamous Cell Carcinoma.

Posted Date: Feb 8, 2017

  • Investigator: Trisha Wise-Draper
  • Co-Investigator: Trisha Wise-Draper
  • Specialties: Hematology/Oncology, Oncology, Cancer
  • Type of Study: Drug

The purpose of this research study is to test the safety of adding metformin to treatment that you will already be getting for your cancer. You will be offered “standard of care” treatment whether you participate in this study or not. The standard of ca

Criteria:

To Be Eligible To Participate, Patients Must Have Head And Neck Cancer That Requires Treatment With Cisplatin And Radiation.

Keywords:

Head & Neck, Ucci-Hn-14-01, Squamous Cell, Cancer, Null

For More Information:

Uc Cancer Institute
513-584-7698
kastla@uc.edu

  • Search Clinical Studies

  • Research in the News

    Targeted Treatment Could Prevent Spread of Pancreatic Cancer, Heart Damage

    Researchers at the UC College of Medicine have shown that a new targetedtreatment could benefit patients with certain pancreatic tumors.